Publications by authors named "Mahaut Lecomte"

Claim this Profile
O
Outcomes after double switching from originator Infliximab to biosimilar CT-P13 and biosimilar SB2 in patients with inflammatory bowel disease: a 12-month prospective cohort study.
Noémie Trystram, Vered Abitbol, Jenny Tannoury, Mahaut Lecomte, Julie Assaraf

Aliment Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis